Skip to content

Home
Science
Pipeline
Careers
News
Contact

Home
Science
Pipeline
Careers
News
Contact

Moonwalk in the news

January 28, 2026

Epigenetic and genetic discovery of novel adipose tissue targets for obesity therapeutics (Keystone Symposium, Obesity Therapeutics 2026, Poster #2031)

November 11, 2025

ObesityWeek 2025

September 24, 2025

Cell Fate Plasticity: From Reprogramming to Early Development (Presentation by Dr. Kathrin Plath, Cold Spring Harbor Laboratory Cell Fate Conversions 2025)

September 16, 2025

Methylencoder: A Transformer Encoder Architecture Trained on Long-Read DNA Methylation Data Achieves Significant Performance Gains by Encoding Each of the 30M CpGs in the Genome and Incorporating Long-Range Fragment-Level Attention (Keystone Symposium: AI in Molecular Biology, Poster #1039)

February 26, 2025

Keystone Symposia: Obesity and Adipose Tissue

February 13, 2026

Exclusive: Feng Zhang’s epigenetic editing startup shifts focus to siRNA obesity therapies

May 2, 2024

ASGCT 2024: Moonwalk Biosciences Presents Multiplex Epigenetic Engineering Platform

January 4, 2024

Moonwalk Bio Grabs $57 Million, Joins Push for ‘Epigenetic’ Treatments

January 4, 2024

Feng Zhang, Grail founder join forces on new gene editing startup, Moonwalk

January 4, 2024

Backed by CRISPR pioneer Feng Zhang, epigenetics biotech Moonwalk debuts with $57M

January 4, 2024

A new startup from Feng Zhang and an ex-Illumina executive zeroes in on the epigenome

January 4, 2024

Moonwalk Biosciences raises $57 million today to pursue epigenome engineering

January 4, 2024

Moonwalk Biosciences Raises $57M to Edit the Epigenome

October 21, 2024

Moonwalk Biosciences to Present New Epigenetic Data at ObesityWeek® 2024 and The Liver Meeting® 2024

August 19, 2024

Moonwalk Biosciences Appoints VP of Biology and Translational Science and Announces Formation of Cardiometabolic Advisory Board

April 22, 2024

Moonwalk Biosciences to Present Data Showcasing EpiRead™ and EpiWrite™ Next-Generation Multiplex Epigenetic Engineering Platform at ASGCT 2024

January 4, 2024

Moonwalk Biosciences Launches with $57 Million in Financing to Advance a New Class of Precision Epigenetic Medicines

© 2026 Moonwalk Biosciences, Inc.

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}